These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25601817)

  • 1. Bone marrow mononuclear cell therapy for acute myocardial infarction: we know what we want, but we just don't know how yet.
    Wollert KC
    Heart; 2015 Mar; 101(5):337-8. PubMed ID: 25601817
    [No Abstract]   [Full Text] [Related]  

  • 2. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial.
    Hirsch A; Nijveldt R; van der Vleuten PA; Tijssen JG; van der Giessen WJ; Tio RA; Waltenberger J; ten Berg JM; Doevendans PA; Aengevaeren WR; Zwaginga JJ; Biemond BJ; van Rossum AC; Piek JJ; Zijlstra F;
    Eur Heart J; 2011 Jul; 32(14):1736-47. PubMed ID: 21148540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
    Hirsch A; Nijveldt R; van der Vleuten PA; Biemond BJ; Doevendans PA; van Rossum AC; Tijssen JG; Zijlstra F; Piek JJ;
    Am Heart J; 2006 Sep; 152(3):434-41. PubMed ID: 16923409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary infusion of bone marrow-derived mononuclear cells contributes to longstanding improvements of left ventricular performance and remodelling after acute myocardial infarction: a meta-analysis.
    Ye Z; Zhang BL; Zhao XX; Qin YW; Wu H; Cao J; Zhang JL; Hu JQ; Zheng X; Xu RL
    Heart Lung Circ; 2012 Nov; 21(11):725-33. PubMed ID: 22898593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and safety of intra-coronary bone marrow mononuclear cell transplantation in ST elevation myocardial infarction patients.
    Srimahachota S; Boonyaratavej S; Rerkpattanapipat P; Wangsupachart S; Tumkosit M; Bunworasate U; Nakorn TN; Intragumtornchai T; Kupatawinturn P; Pongam S; Saengsiri AO; Pothisri M; Sukseri Y; Bunprasert T; Suithichaiyakul T
    J Med Assoc Thai; 2009 Dec; 92(12):1591-6. PubMed ID: 20043559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long term follow-up on emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction].
    Huang RC; Yao K; Zou YZ; Ge L; Qian JY; Yang J; Yang S; Niu YH; Li YL; Zhang YQ; Zhang F; Xu SK; Zhang SH; Sun AJ; Ge JB
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1107-10. PubMed ID: 16796836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction.
    Mathieu M; Bartunek J; El Oumeiri B; Touihri K; Hadad I; Thoma P; Metens T; da Costa AM; Mahmoudabady M; Egrise D; Blocklet D; Mazouz N; Naeije R; Heyndrickx G; McEntee K
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):646-53. PubMed ID: 19698851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow cell therapy after myocardial infarction. What should we select?
    Landmesser U
    Eur Heart J; 2009 Jun; 30(11):1310-2. PubMed ID: 19429633
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network.
    Simari RD; Pepine CJ; Traverse JH; Henry TD; Bolli R; Spoon DB; Yeh E; Hare JM; Schulman IH; Anderson RD; Lambert C; Sayre SL; Taylor DA; Ebert RF; Moyé LA
    Circ Res; 2014 May; 114(10):1564-8. PubMed ID: 24812350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of preconditioned bone marrow mononuclear cells by AT2R stimulation improves infarcted heart function via enhanced cardiac mobilization of implanted cells.
    Xu Y; Hu X; Wang L; Jiang Z; Liu X; Yu H; Zhang Z; Chen H; Chen H; Steinhoff G; Li J; Wang J
    Int J Cardiol; 2013 Oct; 168(4):4551-4. PubMed ID: 23870638
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival.
    Assmus B; Leistner DM; Schächinger V; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Sedding D; Yu J; Corti R; Mathey DG; Barth C; Mayer-Wehrstein C; Burck I; Sueselbeck T; Dill T; Hamm CW; Tonn T; Dimmeler S; Zeiher AM;
    Eur Heart J; 2014 May; 35(19):1275-83. PubMed ID: 24569031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac bone marrow cell therapy: the proof of the pudding remains in the eating.
    Janssens SP
    Eur Heart J; 2011 Jul; 32(14):1697-700. PubMed ID: 21642282
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiomyoplasty with autological mononuclear cells of the bone marrow in patients with acute myocardial infarction].
    Riabov VV; Suslova TE; Krylov AL; Poponina IuS; Vesnina ZhV; Sazonova SI; Markov VA; Popov SV; Karpov RS
    Ter Arkh; 2006; 78(8):47-52. PubMed ID: 17078217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function.
    Sürder D; Manka R; Lo Cicero V; Moccetti T; Rufibach K; Soncin S; Turchetto L; Radrizzani M; Astori G; Schwitter J; Erne P; Zuber M; Auf der Maur C; Jamshidi P; Gaemperli O; Windecker S; Moschovitis A; Wahl A; Bühler I; Wyss C; Kozerke S; Landmesser U; Lüscher TF; Corti R
    Circulation; 2013 May; 127(19):1968-79. PubMed ID: 23596006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.
    Traverse JH; Henry TD; Moye' LA
    Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
    Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials.
    De Luca G; Biondi-Zoccai G; Marino P
    Ann Emerg Med; 2008 Dec; 52(6):665-76. PubMed ID: 19027496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous bone-marrow mononuclear cell transplantation after acute myocardial infarction: comparison of two delivery techniques.
    Silva SA; Sousa AL; Haddad AF; Azevedo JC; Soares VE; Peixoto CM; Soares AJ; Issa AF; Felipe LR; Branco RV; Addad JA; Moreira RC; Tuche FA; Mesquita CT; Drumond CC; Junior AO; Rochitte CE; Luz JH; Rabischoffisky A; Nogueira FB; Vieira RB; Junior HS; Borojevic R; Dohmann HF
    Cell Transplant; 2009; 18(3):343-52. PubMed ID: 19558782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction.
    Huikuri HV; Kervinen K; Niemelä M; Ylitalo K; Säily M; Koistinen P; Savolainen ER; Ukkonen H; Pietilä M; Airaksinen JK; Knuuti J; Mäkikallio TH;
    Eur Heart J; 2008 Nov; 29(22):2723-32. PubMed ID: 18845667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial.
    Heeger CH; Jaquet K; Thiele H; Zulkarnaen Y; Cuneo A; Haller D; Kivelitz D; Schmidt T; Krause K; Metzner A; Schneider C; Kuck KH; Bergmann MW
    EuroIntervention; 2012 Oct; 8(6):732-42. PubMed ID: 23086792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.